Tag: schizophrenia

Profound Brain Changes Found in Patients Who Died of COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The most comprehensive molecular study to date of brain tissue from...

Cortical Surface Changes Tied to Movement Disorders in Schizophrenia

Patients with schizophrenia and parkinsonism show distinctive patterns of cortical surface markers compared with their counterparts without parkinsonism and with healthy controls, results of a...

A Community-Based Mental Health Program Pivots During the Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. For more than 70 years, Fountain House has offered a lifeline...

Emerging Schizophrenia Drugs Target Negative Symptoms

Late-stage trials of new antipsychotic drugs are showing promise in the control of negative symptoms, according to an overview presented by Current Psychiatry and the...

Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon

A novel, ultra-long-acting oral formulation of the antipsychotic risperidone (Risperdal) only needs to be taken once weekly and appears to be safe and effective, results...

Anticholinergics a Key Contributor to Cognitive Impairment

Anticholinergic medication burden from antipsychotics, antidepressants, and other psychotropics has a cumulative effect of worsening cognitive function in patients with schizophrenia, new research indicates. “The...

FDA Okays New Drug Option for Schizophrenia, Bipolar I Disorder

The US Food and Drug Administration (FDA) has approved a once-daily oral medication, which is a combination of olanzapine and samidorphan (Lybalvi, Alkermes), for the...

Blood Biomarker a ‘Promising Predictor’ of Psychosis Relapse

Copeptin, a small peptide secreted with the hormone vasopressin, appears to be one of the first promising biomarkers for predicting psychosis relapse, results of an...

Novel Drug Offers Rapid Relief From Agitation in Serious Mental Illness

An investigational, orally dissolving film formulation of dexmedetomidine (BXCL501, BioXcel Therapeutics) may offer rapid relief from acute agitation related to schizophrenia or bipolar disorder (BD),...

Motor Abnormalities a Harbinger of Serious Mental Illness?

Motor problems in children may be a harbinger of serious mental illness, new research suggests. Investigators found that motor abnormalities were twice as common among...

Potential First-in-Class Schizophrenia Drug Cuts Negative Symptoms

The novel antipsychotic agent SEP-363856 (Sunovion Pharmaceuticals) has a significant and ongoing effect on negative symptoms in patients with schizophrenia, new research shows. Results of...

Include Psych Patients in Next COVID Vaccine Round, APA Urges

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The American Psychiatric Association (APA) is urging the inclusion of patients...

Delusional Infestation Surges During COVID-19 Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Psychiatrists with expertise in delusional infestation have some advice for dermatologists,...

Can I Drink Alcohol While Taking Schizophrenia Medications?

If you have schizophrenia, you may wonder if it’s OK to drink alcohol when taking medications to manage your condition. Doctors say that for most...

APA Apologizes for Past Support of Racism in Psychiatry

The American Psychiatric Association (APA) has issued a formal apology for its past support of structural racism in psychiatry. The apology, issued January 18, coincided...

Billions of Years Old, Lithium Still Has a Promising Future

In a six-decade career spent researching and prescribing lithium ― a long-established therapy for bipolar disorder ― psychiatrist David Dunner, MD, has many stories about...

A Reflection of a Life-Threatening Condition

When a 47-year-old woman with well-controlled schizophrenia attended the Smell and Taste Research Clinic in Chicago, Illinois, Justin Virk, MD, had no idea he was...

Two Genes in Prefrontal Cortex Implicated in PTSD

NEW YORK (Reuters Health) – A post-mortem analysis of brain tissue from people diagnosed with post-traumatic stress disorder (PTSD) revealed that two genes in the...

What’s the Link Between Alcohol and Schizophrenia?

People who have schizophrenia can face a number of challenges: getting a diagnosis, staying on track with treatment, and learning to live with a mental...

Breathing Enriched Oxygen May Improve Major Depression

Breathing enriched oxygen on a nightly basis may lead to clinically meaningful symptomatic improvement in mild to moderate major depression, new research suggests. Dr R....

No Need for Antipsychotics to Recover?

Two new studies highlight the importance of early intervention in first-episode psychosis (FEP). In the first study, Australian investigators conclude that for some FEP patients,...

Aggression Influenced by Genetic, Environmental Factors

Aggression in individuals is influenced by genetic and environmental factors, but can be reduced with treatment, according to Emil F. Coccaro, MD. “It actually is...

ED Visits for Mental Health, Substance Use Doubled in One Decade

Emergency department (ED) visits related to mental health conditions increased nearly twofold from 2007–2008 to 2015–2016, new research suggests. Data from the National Hospital Ambulatory...

Gangstalking forums are hurting people even as some on them try to help

Jenny’s story is not linear, the way that we like stories to be. She was born in Baltimore in 1975 and had a happy, healthy...

LAIs vs Usual Care for First Hospitalization in Early Psychosis

Treatment with a long-acting injectable antipsychotic (LAI) in early-phase schizophrenia can significantly delay time to first hospitalization, new research suggests. The Prevention of Relapse in...